Latest Breaking News On - He cycn us23255m1053 - Page 1 : vimarsana.com

CAMBRIDGE, Mass., March 27, 2023 Cyclerion Therapeutics, Inc. , a clinical-stage biopharmaceutical company on a mission to develop treatments for serious diseases, today announced that the U.S.. | March 27, 2023

United statesUnited kingdomPeter hechtDrug administrationCyclerion therapeutics incChief executive officerDrug designationMitochondrial encephalopathyLactic acidosisCyclerion therapeuticsNc stock exchangePress releaseHe cycn us23255m1053